Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement
American Journal of Clinical Pathology · 2024
DOI: 10.1093/ajcp/aqae060 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2024. Verfasst von Fnu Sameeta und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US. Hauptthemen laut MEDLINE: Immunophenotyping, Leukemia, Myeloid, Acute, Gene Rearrangement, Core Binding Factor beta Subunit. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objectives
We sought to characterize the immunophenotype of acute myeloid leukemia (AML) with CBFB rearrangement and correlate the results with cytogenetic and molecular data.
Methods
Sixty-one cases of AML with CBFB rearrangement were evaluated.
Results
The sample population consisted of 33 men and 28 women, with a median age of 49 years. Flow cytometry immunophenotypic analysis showed that myeloblasts were positive for CD34 and CD117 in all cases, and myeloperoxidase was positive in 52 of 55 (95%) cases. The most common abnormalities included decreased CD38 in 90%, increased CD13 in 85%, increased CD123 in 84%, and decreased HLA-DR in 84% of cases. Monocytes were increased, with a mature immunophenotype, and accounted for 23.7% of total cells. Among 60 cases with available karyotype, inv(16)(p13.1q22) was most common in 50 (83%) cases, followed by t(16;16) (p13.1;q22) in 6 (10%). Type A CBFB::MYH11 transcript was most common, detected in 84% of cases. Mutational analysis showed mutations of NRAS in 37%, FLT3 in 25%, and KIT in 24% of cases. Comparing cases with type A vs non–type A transcripts, blasts in type A cases more frequently exhibited CD64 positivity and increased CD13 levels while showing a lower frequency of CD7 and CD56 expression. Trisomy 22 and mutations in KIT, NF1, and TET2 were identified only in cases with type A transcript.
Conclusions
Myeloblasts of AML with CBFB rearrangement are positive for CD34, CD117, and myeloperoxidase. These neoplasms most frequently carry inv(16)(p13.1q22) and type A fusion transcript. NRAS mutation was the most common mutation. Some immunophenotypic and genetic correlations occurred with different types of transcripts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
- Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, US.
- Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, US.
Zitieren
APA
Sameeta, F., Wang, S. A., Tang, Z., Khoury, J. D., Fang, H., Wang, D., Xu, J., Li, S., Hu, Z., Hu, S., Jorgensen, J. L., Medeiros, L. J., & Wang, W. (2024). Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqae060
Vancouver
Sameeta F, Wang SA, Tang Z, Khoury JD, Fang H, Wang D, et al. Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement. American Journal of Clinical Pathology. 2024. doi:10.1093/ajcp/aqae060
BibTeX
@article{Sameeta2024,
author = {Sameeta, Fnu and Wang, Sa A and Tang, Zhenya and Khoury, Joseph D and Fang, Hong and Wang, Dylan and Xu, Jie and Li, Shaoying and Hu, Zhihong and Hu, Shimin and Jorgensen, Jeffrey L and Medeiros, L Jeffrey and Wang, Wei},
title = {Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement},
journal = {American Journal of Clinical Pathology},
year = {2024},
doi = {10.1093/ajcp/aqae060}
}
EUVIMED